Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

Plasminogen activator inhibitor 1 (PAI-1) has been found to be a bad prognostic factor in a number of tumours but the reason has not been fully explained. The human prostate cancer cell line PC-3 and the human promyelocytic leukaemia cell line HL-60 were used in this study to determine the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwaan, H C, Wang, J, Svoboda, K, Declerck, P J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374508/
https://www.ncbi.nlm.nih.gov/pubmed/10817507
http://dx.doi.org/10.1054/bjoc.2000.1207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374508/
https://www.ncbi.nlm.nih.gov/pubmed/10817507
http://dx.doi.org/10.1054/bjoc.2000.1207

Ejemplares similares